147 results
Page 5 of 8
8-K
EX-99.1
rcf5bhcc2rc74wdz8l2x
5 Nov 20
Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria
6:31am
8-K
EX-99.1
ipb4gs1a w035230dzg
6 Aug 20
Synlogic Reports Second Quarter 2020 Financial Results and Provides Business Update
7:00am
8-K
EX-99.2
rbxs lkvd4oqm4
6 Aug 20
Synlogic Reports Second Quarter 2020 Financial Results and Provides Business Update
7:00am
8-K
EX-99.1
92jhtcabe4 de7
21 May 20
Synlogic Announces Termination of AbbVie Collaboration Agreement
6:15am
8-K
EX-99.1
xw3jq4uefa
8 May 20
Synlogic Reports First Quarter 2020 Financial Results and Provides Business Update
7:15am
8-K
EX-99.1
nciy1u7qqmd
31 Mar 20
Synlogic Provides Summary of Impact of COVID-19 on Clinical Program Progress and Operational Activities
5:07pm
8-K
EX-99.1
4e3u4r
12 Mar 20
Synlogic Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:53pm
8-K
EX-99.1
h80h8x odmp94k
31 Jan 20
Synlogic Appoints Dr. Michael Burgess to its Board of Directors
4:16pm
8-K
EX-99.1
p55iip hnpo3g7w8in15
12 Nov 19
Results of Operations and Financial Condition
4:15pm
8-K
EX-99.1
eit0p 7p13cioz
4 Sep 19
Departure of Directors or Certain Officers
4:05pm
CORRESP
ktprg
30 Aug 19
Correspondence with SEC
12:00am
8-K
EX-99.2
vpr2fm
20 Aug 19
Synlogic DESIGNED FOR LIFE August 2019Corporate Presentation
6:05am
8-K
EX-99.1
c1ga1wgmyms v48bjl
20 Aug 19
Synlogic DESIGNED FOR LIFE August 2019Corporate Presentation
6:05am
UPLOAD
02t x7lb6tzb0x
20 Aug 19
Letter from SEC
12:00am